Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
13,687 total articles
Renesas (RNECF) is an OTC name with thin liquidity, negative technical momentum and massive reported short interest. If management moves to divest or materially restructure its timing/TPD business, buyers like SiTime could capture the upside while Renesas risks getting revalued lower as a streamlined, lower-growth industrial supplier. That scenario…
Zscaler (ZS) has already seen a market re-rating this year on strong AI security traction and improving top-line momentum. The shares trade above key moving averages, institutional interest appears healthy and free cash flow is positive, but trailing multiples remain elevated. This trade idea targets a mid-term swing (45 trading days) long with def…
Verizon trades at a deep yield of ~6.4%, P/E ~11, EV/EBITDA ~7.2 and generates >$21.5B of free cash flow. At $43.70 we built a long-income position sized to produce roughly $1,420 of annual dividend income. This is a long-term (180 trading days) trade: income-first, with upside if valuation normalizes and downside protection via a defined stop loss…
Nokia is trading in a tight band around $9.90 after a huge run earlier this year. Technical momentum is weak, but fundamentals — AI & Cloud order intake and new fiber/access kit — give the stock an asymmetric setup for a range trade. This plan buys near technical support, caps upside at nearby resistance, and keeps risk limited with a clear stop.
Wesco International (WCC) has quietly deepened ties with data center and telecommunications customers through its Communications and Security Solutions segment. With roughly $24 billion in annual sales, improving book-to-bill trends across the tech supply chain, and a P/E near 25, the stock offers a disciplined swing trade: entry at $363.00, stop a…
Nano Labs is a sub-$50M market-cap chip and AI-infrastructure holdco with a large BNB reserve and a pivot toward AI/Web3 convergence. The stock is cheap on a price-to-book basis, technically oversold, and carries asymmetric upside if product commercialization or a strategic partnership materializes. I like a mid-term long — but not the mobile-hardw…
Inventiva (IVA) is trading near its 52-week low at $2.87 while a pivotal Phase 3 readout for lanifibranor in metabolic dysfunction‑associated steatohepatitis (MASH) is expected in Q4 2026. The balance of strong short interest, oversold technicals, recent financing that extended runway, and a market cap of ~$701M creates an asymmetric payoff for dis…
Eaton's multi-year backlog for power transformers and strong data-center demand pair with early signs of margin recovery and solid free cash flow to create a favorable risk-reward for a mid-term swing trade. The stock trades near $428 with a premium multiple, but tangible order coverage and a $3.9B free cash flow run-rate justify a disciplined long…
Microchip is seeing stronger industrial and automotive orders, meaningful traction in edge-AI licensing, and new Ethernet/connectivity product ramps that together justify a tactical long. Valuation metrics look rich on headline P/E, but free cash flow, dividend yield and a cleaner balance sheet provide a margin of safety for a mid-term swing trade …
Tesla looks oversold on headline noise but underpinned by tangible growth levers: Cybercab robotaxi expansion and durable energy storage deployments. Trade long with disciplined risk management while watching earnings and regulatory catalysts.
<p>Seagate is showing clear earnings momentum driven by AI/data-center demand and earlier HAMR adoption. The stock trades well below its 50-day moving averages after a pullback, offering a defined risk-reward for a mid-term swing trade. Valuation remains elevated relative to historical norms, so the trade favors disciplined sizing and a strict stop…
CoreWeave (CRWV) is a high-growth, AI-focused cloud infrastructure provider trading at roughly $78 with a market cap near $44B. The company reported roughly 112% revenue growth and sits on a $104B backlog that underpins multi-year demand. That backlog, combined with a recent pullback and elevated short interest, creates an asymmetric trade: buy at …
Femasys (FEMY) is a sub-$20M market cap medical device company with new European approvals, partnerships, and an $8.0M financing behind an expanded commercial push. The setup is straightforward: management has the regulatory and product pieces in place and recently raised capital to hire and deploy sales. The stock is oversold technically and carri…
EMN is trading near $63 after a pullback that reflects short-term bearish positioning rather than a change in fundamentals. Free cash flow of $539M, an EV/EBITDA of 8.4 and a 5.3% yield support the dividend and leave room for upside. Trade plan targets a rebound to $72 over the next 45 trading days with a protective stop at $58.
Kolibri Global Energy (KGEI) is trading on solid operational momentum and fresh analyst earnings upgrades. With a market cap near $234M, a current price of $6.52, and a forward earnings backdrop that has been revised up, I outline a mid-term swing trade that captures the next leg of upside while protecting capital with a tight stop.
Madison Square Garden Entertainment (MSGE) combines a crowded event calendar, substantial free cash flow and a clean balance sheet. We favor a tactical long into Q1 results and subsequent event tailwinds, with a mid-term horizon to capture a potential re-rating.
Apple is not trying to race to build the largest foundation models. Instead it is embedding smarter AI into devices and services where it already wins: privacy-first on-device features, tighter ecosystem lock-in, and higher-margin services. The balance sheet, cash generation, and services profitability give Apple room to monetize AI on its terms. T…
Apple's combination of high-margin services, accelerating AI-enabled accessories (HomeView launch), and a fortress balance sheet make a clear case for upside to a $6 trillion market cap. This trade lays out an actionable entry, stop, and target with timeline and risk controls — a long-term (180 trading days) position with checkpoints tied to produc…
Palantir is rallying into strong fundamentals: $501B market cap, positive free cash flow, high retention and a growing AI platform. The market still prices perfection (P/S ~81, P/E ~166), but the company’s backlog, government moat, and accelerating commercial AI adoption justify a constructive stance. This trade idea outlines an entry, stop, target…
Innodata has fallen roughly 50% from its 52-week high but is reporting accelerating AI-driven revenue, strong free cash flow and improving operating metrics. The market has punished the stock’s premium multiple; we view that as an opportunity for a mid-term swing aimed at a re-rating if execution continues and commercial pilots convert to recurring…
Takeda trades near $18.50 with a $59B market cap, a 3.1% yield and a reorganized R&D slate that just added a narcolepsy approval. The combination of cash-generative legacy franchises, milestone upside from partnered assets and an improving biotech collaboration footprint make the stock a buy into a 180-trading-day target of $22.00. Use a strict sto…
HubSpot (HUBS) has been pummeled this year amid pricing-change angst and customer-addition headlines. The pullback has left the stock trading near $221 with free cash flow of $797.5M and an FCF multiple near 14x. For disciplined buyers, this is an accumulation opportunity with defined entry, stop, and target levels across short-, mid-, and long-ter…
Sandisk (SNDK) has been a standout beneficiary of the AI memory supercycle, but price action and technicals show a fresh top formation. With bearish momentum, an upcoming 10/29/2026 earnings event, and renewed headlines about Chinese competition, we outline a tactical short: entry at $1456, stop at $1700, target $1100, mid-term (45 trading days) vi…
Buy Microsoft for a mid-term re-rate tied to Azure AI commercialization and enterprise adoption of Copilot; trade plan provided with entry, stop, and targets. The thesis is pragmatic: Microsoft can deliver steady AI-driven top-line improvements and margin leverage separate from raw GPU tailwinds, offering a lower-volatility way to own AI exposure w…
Medpace (MEDP) is trading like a growth business whose pipeline is collapsing. In reality, recent booking cleanup, legal overhang and premium multiples create a better short opportunity than a buy. I recommend a short entry at $620.05 with a target of $520.00 and a stop at $655.00 on a mid-term (45 trading days) horizon.
